CORMEDIX INC (CRMD) Earnings History & Surprises

NASDAQ:CRMDUS21900C3088

Current stock price

6.46 USD
-0.08 (-1.22%)
At close:
6.43 USD
-0.03 (-0.46%)
After Hours:

CRMD Earnings overview

Past quarterly earnings results for CORMEDIX INC (CRMD), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
$0.54
Revenue Estimate
107.08M

Last Reported

Most Recent
Release Date
Mar 5, 2026
Period
Q4 / 2025
EPS Reported
$0.18
EPS Surprise
-78.38%
Revenue Surprise
-0.73%

Beat Rate

Last 8 Quarters
44%
EPS and Revenue beats vs estimates

Quarterly Earnings Historical Results

EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 0.18 0.83 -78.38% -18.18% 128.615M 129.56M -0.73% 312.11%
Q3 2025 1.26 0.66 91.47% 2,620.00% 104.275M 87.743M 18.84% 810.21%
Q2 2025 0.28 0.18 58.80% 212.00% 39.737M 34.712M 14.48% 4,829.39%
Q1 2025 0.30 0.27 13.12% 220.00% 39.082M 37.691M 3.69% -
Q4 2024 0.22 0.14 54.06% 184.62% 31.209M 27.062M 15.32% -
Q3 2024 -0.05 -0.10 52.29% 70.59% 11.456M 11.056M 3.62% -
Q2 2024 -0.25 -0.26 1.96% - 806.12K 1.708M -52.80% -
Q1 2024 -0.25 -0.28 11.68% -4.17% - -
Q4 2023 -0.26 -0.21 -26.35% -30.00% -255K 100.00% -100.00%
Q3 2023 -0.17 -0.21 19.78% - - -100.00%
Q2 2023 -0.25 -0.25 -1.56% -31.58% - -100.00%
Q1 2023 -0.24 -0.20 -17.65% -33.33% - -100.00%
Q4 2022 -0.20 -0.19 -4.85% - 30K 2.377K 1,162.31% -50.00%
Q3 2022 -0.17 -0.23 27.01% 22.73% 10K - -75.00%
Q2 2022 -0.19 -0.21 9.87% -58.33% 20K - 100.00%
Q1 2022 -0.18 -0.22 19.79% 10.00% 10K 25.5K -60.78% -88.89%
Q4 2021 -0.20 -0.24 15.97% -5.26% 60K 19.38K 209.60% -
Q3 2021 -0.22 -0.18 -22.08% - 40K 5.1K 684.31% -55.56%
Q2 2021 -0.12 -0.18 31.80% 14.29% 10K 44.115K -77.33% -50.00%
Q1 2021 -0.20 -0.19 -6.56% 4.76% 90K 139.74K -35.59% 28.57%
Q4 2020 -0.19 -0.22 15.33% - 60K 47.175K 27.19% -
Q3 2020 -0.22 -0.26 15.42% - 90K 38.25K 135.29% -
Q2 2020 -0.14 -0.14 1.96% - 20K 94.35K -78.80% -
Q1 2020 -0.21 -0.23 10.49% - 70K 170.85K -59.03% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

CRMD EPS Q2Q GrowthCRMD EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 0 500 1K 1.5K 2K 2.5K

Revenue Historical Q2Q growth and Acceleration

CRMD Revenue Q2Q GrowthCRMD Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q2/25 Q4/25 Q2/26 Q4/26 0 1K 2K 3K 4K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
3
Average EPS beat (4)
21.25%
Max EPS beat (4)
91.47%
Min EPS beat (4)
-78.38%

Revenue beat statistics

Revenue beat (4)
3
Average Revenue beat (4)
9.07%
Max Revenue beat (4)
18.84%
Min Revenue beat (4)
-0.73%

Analysis

In the last 4 quarters, CRMD has beaten EPS estimates in 3 out of 4 releases
CRMD has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, CRMD has beaten the EPS estimates by 21.3% on average.
In the last 4 quarters, CRMD has beaten the revenue estimates by 9.1% on average.

CORMEDIX INC / CRMD Earnings FAQ

What is the most recent earnings date for CRMD stock?

CORMEDIX INC (CRMD) last reported earnings on 3/5/2026.

Did CRMD stock beat earnings estimates in the most recent quarter?

CORMEDIX INC (CRMD) missed EPS estimates and missed revenue estimates in the most recent quarter.

Can you provide information on how often CORMEDIX INC beats earnings estimates?

In the last 4 quarters, CORMEDIX INC (CRMD) has beaten EPS estimates in 3 out of 4 releases.